A detailed history of Ever Source Wealth Advisors, LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 71 shares of VKTX stock, worth $3,792. This represents 0.0% of its overall portfolio holdings.

Number of Shares
71
Previous 62 14.52%
Holding current value
$3,792
Previous $3,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$49.84 - $70.47 $448 - $634
9 Added 14.52%
71 $4,000
Q2 2024

Aug 13, 2024

BUY
$47.39 - $80.2 $473 - $802
10 Added 19.23%
62 $3,000
Q1 2024

Jun 11, 2024

BUY
$17.4 - $94.5 $904 - $4,914
52 New
52 $4,000

Others Institutions Holding VKTX

About Viking Therapeutics, Inc.


  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $4.1B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Ever Source Wealth Advisors, LLC Portfolio

Follow Ever Source Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ever Source Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ever Source Wealth Advisors, LLC with notifications on news.